Form 4: Guardant Health CFO Michael Bell Reports Stock Transactions
SEC Form 4 Filing
Michael Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent stock transactions to cover tax obligations.
Summary
- On February 1, 2025, Michael Bell, the Chief Financial Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
- Bell vested 6,617 performance-based restricted stock units (PBRSUs).
- To cover tax withholding obligations related to the vesting, 2,361 shares were withheld by the company at a price of $46.98 per share.
- Following these transactions, Bell directly owns 33,177 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's stock transactions related to vested equity compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the CFO's equity compensation and related tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of earliest transaction: Vesting of performance-based restricted stock units and stock withholding for tax obligations. |
| 02/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.